Advancing Translational Research Collaborations

See allHide authors and affiliations

Science Translational Medicine  22 Dec 2010:
Vol. 2, Issue 63, pp. 63cm30
DOI: 10.1126/scitranslmed.3001636


  • Fig. 1. Building bridges.

    Distinguished panelists give their 30,000-foot views on future opportunities and unmet needs in translational research. From right to left: Terry Fadem, managing director of corporate alliances for the University of Pennsylvania; Evan Loh, senior vice president of biotherapeutics development and strategic operations, Pfizer, Inc.; William New, The Novent Group; Janet Woodcock, director, Center for Drug Evaluation and Research; Barry Coller, vice president of medical affairs and physician-in-chief, The Rockefeller University; David Kendall, chief scientific and medical officer, American Diabetes Association; and Elizabeth Stoner, managing director, MPM Capital.


Stay Connected to Science Translational Medicine

Navigate This Article